Stocks
Reunion Neuroscience Inc.REUN
NASDAQHealthcareBiotechnology$1.12-0.89%
A clinical-stage drug development company focused on psychedelic-inspired therapies for mental health disorders, including postpartum depression and other mood conditions. Its lead programs center on novel serotonergic compounds designed for rapid-acting psychiatric treatment. Investors monitor the ...
Market Cap: $13.1M52W Range: $0.63 – $21.56
Congressional Interest in Reunion Neuroscience Inc. (REUN)
No congressional trades have been disclosed for Reunion Neuroscience Inc. (REUN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading REUN?
No congressional trades found for this stock.